Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
American Renal Associates runs outpatient kidney dialysis clinics in the U.S. through partnerships with local doctors.
American Renal Associates is a kidney dialysis company. It runs outpatient clinics that clean patients' blood when their kidneys can no longer do the job, and it serves people with end-stage renal disease โ patients whose kidneys have failed and who need dialysis regularly to stay alive.
What makes the company a little different from a plain chain of clinics is its partnership model. Instead of owning every center outright, American Renal Associates typically teams up with local kidney doctors, who hold a stake in the clinic they work in. That gives the doctors a real reason to send patients there and to keep the place running well, while the company handles the business side. Patients usually don't pay directly; the money comes mostly from Medicare and private insurers, which reimburse the cost of treatment. The company was once listed on the New York Stock Exchange under the ticker ARA, but its shares no longer trade publicly. In 2021 it was taken private by affiliates of private-equity firm Centerbridge Partners, alongside the company's own management and a group of doctors โ so today it is owned by private investors rather than public shareholders.
Dialysis is a steady, recurring business: patients need treatment several times a week, and there is no easy substitute. That dependability is attractive, but the company operates in a crowded field. Big rivals like Fresenius Medical Care and DaVita dominate the industry, and because so much of the revenue flows through government insurance programs, changes to Medicare reimbursement rules can swing the business in a hurry.
Saved answer ยท last researched 16 Nov 2026